Underprescription of Step III Opioids in French Cancer Survivors With Chronic Pain: A Call for Integrated Early Palliative Care in Oncology

Janah, Asmaa; Bouhnik, Anne-Déborah; Touzani, Rajae; Bendiane, Marc-Karim; Peretti‐Watel, Patrick

doi:10.1016/j.jpainsymman.2019.10.027

Cited by 9 publications

(6 citation statements)

References 64 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Conflicting with the CDC guidelines, the latest U.S. government pain management guidelines emphasize the necessities and risks of opioid analgesics (Pain Management Best Practices Inter-Agency Task Force, US Department of Health and Human Services, 2020). opioid analgesics to achieve pain relief, possibly due to an insufficient dosage of the prescribed analgesic relative to the pain level (Chow et al, 2017;Janah et al, 2020;Makhlouf et al, 2020;Oldenmenger et al, 2009;Xia, 2017). Considering the widely varied differences in individual opioid sensitivity, tailored analgesic strategies for each patient would be ideal, but appropriate opioid management is sometimes difficult (i.e., optimization of initial dosages, effective dose titration, and achievement of maintenance dosages).…”

Section: Reviewmentioning

confidence: 99%

“…Considering the widely varied differences in individual opioid sensitivity, tailored analgesic strategies for each patient would be ideal, but appropriate opioid management is sometimes difficult (i.e., optimization of initial dosages, effective dose titration, and achievement of maintenance dosages). A systematic review of the barriers hindering adequate cancer-related pain management revealed not only the inadequate assessment of pain but also health-care professional's inadequate knowledge of pain management (Chow et al, 2017;Janah et al, 2020;Makhlouf et al, 2020;Oldenmenger et al, 2009;Xia, 2017). In particular, many physicians and nurses demonstrate an inadequate knowledge of opioid analgesics (e.g., effective dose, management of adverse effects, and likelihood of addiction or tolerance).…”

Section: Reviewmentioning

confidence: 99%

“…In particular, many physicians and nurses demonstrate an inadequate knowledge of opioid analgesics (e.g., effective dose, management of adverse effects, and likelihood of addiction or tolerance). The reluctance of health-care providers to prescribe, and of patients and their families to adhere to opioid analgesics, as well as the fear of dependence and other side effects are barriers to effective management of cancer-related pain (Chow et al, 2017;Janah et al, 2020;Makhlouf et al, 2020;Xia, 2017). To achieve adequate opioid availability, these barriers should be overcome in a clinically suitable manner.…”

Section: Reviewmentioning

confidence: 99%

“…Because opioid analgesics are still the most potent analgesics for not only nociceptive (inflammatory) pain but also neuropathic pain (Finnerup et al, 2015), cancer-related pain in cancer survivors might be refractory to other analgesics and thus necessitate the continued prescription of opioid analgesics. In fact, the reluctance of physicians to prescribe opioid analgesics for cancerrelated pain in cancer survivors and its poor management have been reported (Janah et al, 2020). In case of cancer survivors, lower dosages and shorter duration of opioid treatment would be deservingly eligible.…”

Section: Future Per S Pec Tive S Of Improving Opi Oid Avail Ab Ilit Y...mentioning

confidence: 99%

See 3 more Smart Citations

Genetic implications in quality palliative care and preventing opioid crisis in cancer‐related pain management

Sumitani

Nishizawa

Hozumi

et al. 2020

J of Neuroscience Research

View full text Add to dashboard Cite

The prevalence of cancer-related pain is 64% among patients with metastatic, advanced, or terminal cancer, 59% among patients undergoing anticancer treatment, and 33% among patients who completed curative treatment. According to the World Health Organization cancer pain relief guidelines, opioid analgesics are the mainstay analgesic therapy in addition to conventional first-step analgesics, such as nonsteroidal anti-inflammatory drugs and acetaminophen. The indications for strong opioids have recently been expanded to include mild-to-moderate pain in addition to moderate-to-severe pain. The U.S. Centers for Disease Control and Prevention guidelines emphasize that realistic expectations should be weighed against potential serious harm from opioids, rather than relying on the unrealized long-term benefits of these drugs. Therefore, treatment strategies for both cancer-related chronic or acute pain have been unfortunately deviated from opioid analgesics. The barriers hindering adequate cancer-related pain management with opioid analgesics are related to the inadequate knowledge of opioid analgesics (e.g., effective dose, adverse effects, and likelihood of addiction or tolerance). To achieve adequate opioid availability, these barriers should be overcome in a clinically suitable manner. Genetic assessments could play an important role in overcoming challenges in opioid management. To balance the improvement in opioid availability and the prevention of opioid misuse and addiction, the following two considerations concerning opioids and genetic polymorphisms warrant attention: (A) pain severity, opioid sensitivity, and opioid tolerance; and (B) vulnerability to opioid dependence and addiction.

show abstract

Section: Reviewmentioning

confidence: 99%

Section: Reviewmentioning

confidence: 99%

Section: Reviewmentioning

confidence: 99%

Section: Future Per S Pec Tive S Of Improving Opi Oid Avail Ab Ilit Y...mentioning

confidence: 99%

See 2 more Smart Citations

Genetic implications in quality palliative care and preventing opioid crisis in cancer‐related pain management

Sumitani

Nishizawa

Hozumi

et al. 2020

J of Neuroscience Research

View full text Add to dashboard Cite

show abstract

“…Moreover, anxiety can combine with other psychological problems in cancer patients. The research conducted in China shows the prevalence of anxiety, depression, or anxiety combined with depression in cancer patients that accounts for 21.1%, 34.4% and 15.6%, respectively (11).…”

Section: Introductionmentioning

confidence: 99%

Effects of Ayatul Kursi on anxiety and pain levels in adult hematological cancer patients Islamabad, Pakistan

Ahmed¹,

Huda

Rubab

2022

ijhs

View full text Add to dashboard Cite

Background: Cancer is a life threatening disease and considered the leading cause of death in low-income countries. Anxiety and pain are the most common problems experienced by the cancer patients. Purpose: The purpose of this study was to determine the effects of Ayatul Kursi on anxiety and pain levels in adult hematological cancer patients admitted in oncology in-patient units of tertiary care hospital. Methodology: This study was a time series Qusai experimental pretest post-test design conducted in tertiary care hospital, Islamabad, Pakistan. The total sample size was 35 patients; those patients who met the inclusion criteria were conveniently sampled. Patient anxiety level was measured on Generalized Anxiety Disorder-7 (GAD-7) scale and pain level was measured on Numerical Rating Scale (NRS).The intervention was recorded recitation of Ayatul Kursi in the voice of Qari Abdul Basit, with an Urdu translation. Patients listen ten times to the recitation on an MP3 player with the help of earphones. Two cycles were given to the patient in a day and intervention was given to the patients for three days. Data was recorded before giving the intervention on day one. The second data was recorded immediately after evening dose of the intervention on day two.

show abstract

Definition of Survivorship Care

Strasser

2021

Survivorship Care for Cancer Patients

View full text Add to dashboard Cite

Underprescription of Step III Opioids in French Cancer Survivors With Chronic Pain: A Call for Integrated Early Palliative Care in Oncology

Cited by 9 publications

References 64 publications

Genetic implications in quality palliative care and preventing opioid crisis in cancer‐related pain management

Genetic implications in quality palliative care and preventing opioid crisis in cancer‐related pain management

Effects of Ayatul Kursi on anxiety and pain levels in adult hematological cancer patients Islamabad, Pakistan

Definition of Survivorship Care

Contact Info

Product

Resources

About